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532median age 82 years; range 70 to 88 years). Four patients were
symptomatic for dyspnea (New York Heart Association functional
class II); 1 had a pacemaker; 2 were receiving antihypertensive
therapy; carpal tunnel syndrome had been previously diagnosed in 3.
None had overt neurologic symptoms. ECG was abnormal in all
cases: atrial ﬁbrillation in 3 cases, left anterior hemiblock in 2,
isolated ST-T abnormalities in 4, abnormal Q waves in 3, and low
QRS voltage in 2. Increased left ventricular (LV) wall thickness was
detected in all patients (mean LV wall thickness, 14 mm; inter-
quartile range: 13 to 15 mm), and LV ejection fraction was 58%
(interquartile range: 54% to 67%). Other echocardiographic ab-
normalities included mild pericardial effusion (n ¼ 6), A-V valve
thickening (n ¼ 5), and myocardial granular sparkling (n ¼ 8). LV
“hypertrophy” was completely unexplained in 10 patients and was
out of proportion in 4 (moderate systemic hypertension with non-
dilated LV and ascending aorta). Genetic analysis was performed in
6 cases and documented an Ile68Leu TTR mutation in a single
patient. Endomyocardial biopsy was performed in the remaining 5
patients and detected TTR-related amyloidosis in all, leading to a
ﬁnal diagnosis of wild-type TTR amyloidotic cardiomyopathy (se-
nile systemic amyloidosis [SSA]).
In this large cohort of subjects undergoing 99mTc-DPD scintig-
raphy for different reasons, 45 (0.36%) showed unexpected
myocardial tracer uptake. We cannot exclude a slight underestima-
tion of the real prevalence because of the retrospective nature of the
study. The subsequent cardiological evaluation revealed an unex-
plained increase of LV wall thickness in all the analyzed cases, and
endomyocardial biopsy conﬁrmed the diagnosis of TTR-
related amyloidosis in all the patients who underwent the proce-
dure. The impact of our study, albeit small, mainly relies on the
possibility of an early (pre-clinical) identiﬁcation of patients affected
by TTR-related amyloidotic cardiomyopathy, mainly the form
related to the deposition of wild-type TTR, a condition that is
believed to be highly underdiagnosed. There are currently no reliable
studies regarding the prevalence of SSA. If we consider all our pa-
tients with myocardial 99mTc-DPD uptake to be affected by TTR-
related cardiomyopathy (mainly SSA), the prevalence of the disease
would reach 1.4% among men in the ninth decade. It is noteworthy
that although SSA is known to mainly affect elderly men, a relevant
number of women showed asymptomatic myocardial tracer uptake.
Finally, our data require conﬁrmation through prospective studies,
but, if conﬁrmed, they would suggest the possibility of using 99mTc-
DPD scintigraphy as a screening tool in populations at risk. With the
advent of new drugs aimed at halting TTR deposition that are
currently under clinical evaluation (4), an early diagnosis of the dis-
ease is highly encouraged and should be pursued.
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Diagnostic Problem of
LV Hypertrabeculation/
Noncompaction?
With interest we read the article by Stacey et al. (1) about systolic
and diastolic criteria for left ventricular hypertrabeculation/non-
compaction (LVHT). Uniform diagnostic criteria for LVHT are a
still unsolved problem in echocardiography as well as other imaging
modalities like cardiac magnetic resonance (CMR). Whether the
results of their investigations will lead to more clariﬁcation is
questionable due to the following reasons: 1) No pathoanatomic
gold standard is provided; thus, neither sensitivity nor speciﬁcity of
the proposed criteria can be assessed. 2) It remains uncertain in how
many patients LVHT was diagnosed by echocardiography. There is
a need to calculate the percentage of LVHT patients in whom
LVHT was diagnosed on echocardiography and CMR, on CMR
but not on echocardiography and on echocardiography but not on
CMR. 3) The duration and quality of follow-up remain uncertain.
Were follow-up data obtained for each of the included patients? 4)
Differentiation between LVHT on the one hand and papillary
muscles, false tendons, and aberrant bands on the other is a difﬁcult
issue because these structures are seen frequently, and there is
considerable anatomic variability (2,3). To our knowledge, the
proposed “papillary muscle classiﬁcation system” is not based on any
pathoanatomic classiﬁcation. Furthermore, it seems rather difﬁcult
to differentiate between papillary muscles and trabeculations when
only short-axis views are considered. Only by using longitudinal
views will it be possible to visualize the communication of the
papillary muscles with the mitral valve leaﬂets via the chordae ten-
dineae. Not to differentiate between LVHT and papillary muscles is
not acceptable because LVHT diagnostic criteria deﬁnitions clearly
exclude papillary muscles from the evaluation. 5) There is no need to
distinguish between “myopathic LVHT” and “normal variants”
because they are morphologically the same and have a similar
complication rate and outcome. Normal variants may have sub-
clinical myopathy or may have chromosomal abnormalities, which
manifest only in the heart. This is why we recommend referring all
LVHT patients to a myologist to also detect neurological abnor-
malities which are clinically inapparent for the cardiologist. As an
initial step, the authors should provide information about how many
of their patients had an elevated creatine kinase level and in how
many patients was LVHT familial. Familial LVHT may suggest
hereditary disease, including neuromuscular disorders.
Additionally, we have the following questions regarding the pre-
sented data. 1) It was previously reported that echocardiographically
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533diagnosed LVHT is more often visible on CMR in patients with an
enlarged left ventricle and systolic dysfunction than in those with
normal-size, well-contracting left ventricles (4). Did any of the
patients undergo follow-up CMR studies and did the ratios of non-
compacted to compacted layers and the trabecular mass change? 2)
From pathoanatomic investigation we know that endocardial ﬁbrosis
is frequently found in LVHT patients (5). Was that phenomenon
also visible on CMR? 3) Because of unknown reasons, LVHT was
diagnosed more frequently in male than female patients. How can
the relatively high proportion of female patients in the present study be
explained?
In conclusion, only close cooperation between cardiologists,
radiologists, neurologists, and cardiac pathologists will solve the
enigmas of LVHT.
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We thank Drs. Stollberger and Finsterer for their interest in our
recent publication (1). They raised several points that will help
clarify future discussions regarding left ventricular noncompaction
(LVNC).
Although the criteria for LVNC cardiomyopathy are evolv-
ing, the phenotypic characterization has been previously reported.
We used standard criteria based on the end-systolic (2), end-
diastolic (3), trabecular mass (4) ratio and ensured the presence of
apical trabeculations with blood noted in trabecular recesses.
Furthermore, we observed 88% concordance between systolic
criteria with cardiac magnetic resonance and interpretable echo-
cardiography in our patient cohort. In our experience, the mostcommon cause of overdiagnosis is the singular dependence on the
long-axis views. An obliquely imaged papillary muscle in the long
axis may give the appearance of trabeculation instead of papillary
muscle because the long-axis cardiac images are optimized for wall
motion analysis and not papillary muscle anatomy. By using the
short- and long-axis views together, an interpreter has the oppor-
tunity to distinguish between papillary muscle and trabeculation. As
to whether some trabeculation may represent normal variants,
43% of the MESA (Multi-Ethnic Study of Atherosclerosis) popu-
lation had 1 segment with an end-diastolic noncompacted to
compacted ratio >2.3 (5). The clinical relevance of a single-
segment pattern is uncertain. Our patients had multiple seg-
ments involved and occasional right ventricular involvement. Of
note, no LVNC pattern criteria were associated with late gadolin-
ium enhancement, making inﬁltrative or idiopathic disease such as
endomyocardial ﬁbrosis unlikely. Among the 8 patients who had
serial cardiac magnetic resonance evaluation, no substantive changes
in the pattern of LVNC were appreciated.
We agree that a pathoanatomic gold standard is lacking
at this time; however, increased recognition and longitudinal clinical
care may yield a pathway to obtaining tissue and address these
concerns. Patients in our study did not have diagnoses of neuro-
muscular disorders or congenital heart disease and were not bio-
logically related. Although a longer duration of clinical follow-up
would be ideal, a mean follow-up of 500 days in our cohort does
provide clinically useful short- and intermediate-term information.
Concerns regarding genotypic myopathies as a clinical subset are not
answered by our data, and future proposed collaboration may help to
investigate these associations.
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